Talus Bioscience develops drugs targeting "undruggable" transcription factors to treat cancer and diabetes using functional proteomics and machine learning.
Employees
16
Founded
2020
Revenue
$1-5M
Company Stage
Seed
YC Batch
S21
Product Features & Capabilities
MARMOT platform for targeting transcription factors, functional proteomics, automated biology, machine learning for drug development, focus on hard-to-treat transcription factor proteins.